Richard J. Pariza

Dr. Pariza joined SAJE in 2013 and has been instrumental in developing the Company’s chemistry program. He has designed and synthesized novel GSNOR inhibitors using the Company’s proprietary structural-activity knowledge. Many of those molecules are advancing in preclinical evaluations.

Dr. Pariza started his pharmaceutical career at Abbott Laboratories Pharmaceutical Division in the chemistry group designing and synthesizing novel molecules for various targets. As well, he founded and ran a process research group. After Abbott, Dr. Pariza was a consultant to G.D. Searle and other pharmaceutical companies on chemistry related issues. He has also been a lead chemist at the senior executive level for a number of biopharmaceutical companies including Protarga, Natural Pharmaceuticals, Cedarburg Pharmaceuticals, OncQuest, Inc., and C-NOF Pharmaceuticals.

Dr. Pariza received a B.S. degree in chemistry from the University of Wisconsin and a Ph.D. from Purdue University in organic chemistry. Dr. Pariza has authored 16 issued patents and 24 peer-reviewed scientific publications and numerous abstracts, book chapters, and published symposium talks.